DHEA-S: How to Interpret Your Result

What Is DHEA-S and Why Does It Matter?

DHEA-S is the sulfated form of DHEA, a precursor hormone that the body converts into testosterone, estradiol, and other sex steroids. The adrenal cortex (zona reticularis) produces more than 95% of circulating DHEA-S, making it the single best blood marker of adrenal androgen activity [1]. Unlike DHEA itself, which has a short half-life and fluctuates throughout the day, DHEA-S circulates at concentrations 300-500 times higher and remains stable across the 24-hour cycle [2].

Why Clinicians Order This Test

Physicians order DHEA-S to evaluate suspected androgen excess (hirsutism, acne, irregular periods in women), adrenal insufficiency, or unexplained fatigue. The Endocrine Society's 2018 clinical practice guideline on hirsutism recommends measuring DHEA-S alongside total testosterone as a first-line screen to differentiate ovarian from adrenal sources of androgen excess [3].

DHEA-S as an Aging Biomarker

Research from the Baltimore Longitudinal Study of Aging confirmed that DHEA-S declines with age more predictably than almost any other hormone [4]. By age 70-80, circulating levels may be only 10-20% of their peak value. This decline has prompted interest in DHEA supplementation for age-related conditions, though evidence of benefit remains mixed (covered below).

Normal DHEA-S Ranges by Age and Sex

Reference ranges for DHEA-S depend heavily on age. A value of 80 mcg/dL would be abnormally low for a 25-year-old woman but entirely normal for a 75-year-old woman. The table below reflects ranges commonly reported by major reference laboratories [5].

| Age Range | Females (mcg/dL) | Males (mcg/dL) | |-----------|-------------------|-----------------| | 18-29 | 148-407 | 211-492 | | 30-39 | 98-340 | 160-449 | | 40-49 | 61-285 | 88-427 | | 50-59 | 35-256 | 51-295 | | 60-69 | 13-130 | 33-249 | | 70-79 | 17-90 | 16-167 |

Why Ranges Differ Between Labs

Labs use different immunoassay platforms (Roche Cobas, Siemens Immulite, Abbott Architect), each with slightly different calibration standards and antibody specificity. A 2017 study comparing six commercial DHEA-S assays found inter-assay coefficients of variation as high as 20% at the same sample concentration [6]. Always interpret your result against the reference range printed on your lab report, not a range from a different laboratory.

The Importance of Age-Matched Comparison

The Endocrine Society emphasizes that DHEA-S results should be compared to age- and sex-matched reference intervals rather than a single "normal" cutoff [3]. A 28-year-old woman with a DHEA-S of 500 mcg/dL might warrant investigation for PCOS or nonclassic congenital adrenal hyperplasia (NCAH), while the same absolute number in a 28-year-old man falls within the expected range.

What Does a High DHEA-S Mean?

An elevated DHEA-S points toward the adrenal glands as the source of excess androgen. The clinical significance depends on how high the value is, the patient's age and sex, and what symptoms are present.

Mildly Elevated DHEA-S (Up to ~700 mcg/dL in Women)

Mild elevations are common in polycystic ovary syndrome (PCOS). Roughly 20-30% of women with PCOS have an elevated DHEA-S, according to data from the 2023 international evidence-based PCOS guideline endorsed by the Endocrine Society and the European Society of Endocrinology [7]. In these cases, DHEA-S alone does not confirm or exclude PCOS; clinicians evaluate it alongside total testosterone, free testosterone, menstrual history, and ultrasound findings.

Nonclassic congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency is another frequent cause. NCAH affects an estimated 1 in 200 individuals in the general population and up to 1 in 27 in Ashkenazi Jewish populations [8]. A morning 17-hydroxyprogesterone level above 2 ng/mL (basal) or above 10 ng/mL after cosyntropin stimulation confirms the diagnosis [8].

Markedly Elevated DHEA-S (>700 mcg/dL in Women, >600 mcg/dL in Postmenopausal Women)

Very high DHEA-S values, particularly values above 700 mcg/dL in premenopausal women or rapidly rising levels at any age, raise concern for an adrenal androgen-secreting tumor. The Endocrine Society recommends cross-sectional adrenal imaging (CT or MRI) when DHEA-S exceeds the upper limit of the age-matched reference range by a large margin or when virilization progresses rapidly [3].

Interpreting High DHEA-S: A Decision Framework

1. Mild elevation + hirsutism/irregular periods in a young woman → Evaluate for PCOS (Rotterdam criteria) and NCAH (17-OHP, consider cosyntropin stimulation test).
2. Moderate elevation + no clear PCOS features → Check morning cortisol, 17-OHP, androstenedione, and consider adrenal CT if the clinical picture is unclear.
3. Marked elevation (>700 mcg/dL) or rapid onset of virilization → Urgent adrenal imaging; refer to endocrinology.
4. Elevated DHEA-S in a child or adolescent → Evaluate for premature adrenarche, NCAH, or rare adrenal tumors; check bone age.

What Does a Low DHEA-S Mean?

A low DHEA-S can reflect normal aging, adrenal insufficiency, long-term glucocorticoid use, or hypothalamic-pituitary disease.

Age-Related Decline vs. Pathology

Because DHEA-S falls steadily after the third decade, a "low" reading in someone over 60 may simply reflect normal adrenal aging (adrenopause). The clinical question is whether the value is low for that patient's age bracket. A 2004 study published in the Journal of Clinical Endocrinology & Metabolism (N=981) found that DHEA-S below the 10th percentile for age was associated with increased cardiovascular mortality in men over 50, though a causal link was not established [9].

Primary Adrenal Insufficiency (Addison Disease)

In Addison disease, the adrenal cortex is destroyed by autoimmune attack, infection, or hemorrhage. DHEA-S is often profoundly low alongside low cortisol and elevated ACTH. The Endocrine Society's 2016 guideline on adrenal insufficiency recommends a morning cortisol and ACTH as the primary diagnostic tests, with a cosyntropin stimulation test for confirmation [10]. DHEA-S is supportive, not diagnostic, in this context.

Medication-Induced Suppression

Exogenous glucocorticoids (prednisone, dexamethasone, inhaled corticosteroids at high doses) suppress ACTH and, consequently, adrenal DHEA-S output. Patients on chronic glucocorticoids for asthma, autoimmune disease, or organ transplantation often have DHEA-S levels well below the age-matched reference range [10].

Hypopituitarism

When the pituitary gland fails to produce adequate ACTH (due to tumors, surgery, radiation, or traumatic brain injury), adrenal androgen production falls. Low DHEA-S in this setting accompanies low cortisol and low ACTH. A comprehensive pituitary hormone panel is indicated.

How to Lower DHEA-S

Treatment targets the underlying cause of elevation, not the DHEA-S number itself.

Lifestyle Approaches

Regular moderate-intensity exercise (150 minutes per week, per current American Heart Association guidelines) may modestly reduce adrenal androgen output in women with PCOS [11]. Weight loss of 5-10% of body weight in overweight women with PCOS has been shown to reduce circulating androgens, improve menstrual regularity, and improve insulin sensitivity in randomized trials [7].

Pharmacologic Options

Combined oral contraceptives (COCs) are first-line for managing hyperandrogenism in women who are not seeking pregnancy. COCs suppress gonadotropin-driven ovarian androgens and raise sex hormone-binding globulin (SHBG), which lowers free testosterone. Their direct effect on DHEA-S is modest, since DHEA-S is adrenal in origin [3].

For NCAH, low-dose glucocorticoids (hydrocortisone 10-15 mg/m² per day or dexamethasone 0.25-0.5 mg at bedtime) suppress excess ACTH drive and reduce adrenal androgen production. The 2018 Endocrine Society congenital adrenal hyperplasia guideline recommends the lowest effective glucocorticoid dose to avoid Cushingoid side effects [12].

Anti-androgens such as spironolactone (50-200 mg daily) block androgen receptor binding and are commonly used alongside COCs for moderate-to-severe hirsutism. Spironolactone does not directly lower DHEA-S but attenuates the downstream effects of excess androgens [3].

How to Raise DHEA-S

Low DHEA-S in the setting of adrenal insufficiency is managed by treating the underlying condition. For age-related decline, the evidence for supplementation is less clear.

DHEA Supplementation: What the Evidence Shows

Oral DHEA supplements (typically 25-50 mg daily) raise circulating DHEA-S levels within weeks. A 2006 randomized, double-blind, placebo-controlled trial (N=280, ages 60-79) published in PLOS Medicine found that 50 mg of oral DHEA daily for one year significantly raised DHEA-S levels but produced no measurable improvements in body composition, physical performance, glucose tolerance, or quality of life in either sex [13].

The Endocrine Society's 2014 scientific statement on DHEA noted that evidence does not support DHEA supplementation for anti-aging purposes in the general population [14]. However, the same statement acknowledged a potential role for DHEA replacement in women with primary or secondary adrenal insufficiency. A Cochrane review of DHEA for adrenal insufficiency (2015, 10 trials, N=549) found modest improvements in health-related quality of life and depression scores in women, but heterogeneity across trials limited the strength of the conclusion [15].

When DHEA Replacement May Be Appropriate

The Endocrine Society's 2016 adrenal insufficiency guideline suggests a time-limited trial (6-12 months) of DHEA 25-50 mg daily in women with adrenal insufficiency who report impaired well-being, low libido, or depressive symptoms despite optimized cortisol and thyroid replacement [10]. The guideline recommends monitoring DHEA-S levels to keep them within the mid-normal range for young women.

Dr. Wiebke Arlt, then professor of medicine at the University of Birmingham and lead author of landmark DHEA trials, stated: "DHEA replacement in adrenal insufficiency is not about anti-aging. It is about restoring a hormone that the damaged adrenal gland can no longer produce" [10].

Practical Considerations for DHEA Supplements

DHEA is sold over the counter in the United States as a dietary supplement (regulated under DSHEA, not as a prescription drug by the FDA). This means product quality, dosing accuracy, and purity vary by manufacturer. Third-party testing services (USP, NSF International, ConsumerLab) can help verify product quality.

Patients should not self-prescribe DHEA without baseline bloodwork and follow-up testing. Excess DHEA supplementation can increase testosterone and estradiol, potentially worsening acne, hair loss, or hormone-sensitive conditions.

How DHEA-S Fits Into a Broader Hormone Panel

DHEA-S is rarely ordered in isolation. Its clinical value increases when read alongside other biomarkers.

Pairing DHEA-S With Other Tests

For suspected androgen excess: Total testosterone, free testosterone (calculated or equilibrium dialysis), SHBG, androstenedione, 17-hydroxyprogesterone, prolactin, and TSH. This combination helps distinguish PCOS, NCAH, Cushing syndrome, and androgen-secreting tumors [3].

For suspected adrenal insufficiency: Morning cortisol (drawn between 7-9 AM), ACTH, comprehensive metabolic panel, and aldosterone/renin. If screening cortisol is equivocal (between 3-15 mcg/dL), a cosyntropin (ACTH 250 mcg) stimulation test is the next step [10].

For aging and longevity panels: DHEA-S is commonly bundled with IGF-1, fasting insulin, HbA1c, lipid panel, and inflammatory markers (hsCRP, homocysteine). While this combination gives a broad metabolic picture, no guideline body currently recommends routine DHEA-S screening in asymptomatic adults as part of preventive care.

Reading DHEA-S in Context With Cortisol

A low DHEA-S with a normal morning cortisol may indicate early zona reticularis decline (the adrenal zone that preferentially produces DHEA-S) before overt cortisol deficiency appears [2]. A low DHEA-S with a low cortisol strongly suggests adrenal insufficiency and warrants stimulation testing.

A high DHEA-S with a high cortisol and clinical features of Cushing syndrome raises suspicion for ACTH-dependent hypercortisolism. In this scenario, midnight salivary cortisol, 24-hour urinary free cortisol, and low-dose dexamethasone suppression testing are indicated per the Endocrine Society's 2008 Cushing syndrome guideline [16].

When to Recheck DHEA-S

Because DHEA-S has a long half-life (7-10 hours) and circulates at high concentrations, single measurements are generally reliable. Repeat testing is appropriate in specific situations.

Follow-Up Timing

After starting DHEA supplementation, recheck at 4-6 weeks to confirm levels are in the target range. After initiating glucocorticoid therapy for NCAH, recheck DHEA-S and 17-OHP at 3 months to assess suppression adequacy [12]. For monitoring purposes in PCOS, annual DHEA-S alongside testosterone and metabolic markers is reasonable.

Discordant or Unexpected Results

If a single DHEA-S result does not match the clinical picture (e.g., a markedly elevated DHEA-S in a patient with no signs of androgen excess), consider repeating the test before proceeding to imaging. Assay interference from heterophilic antibodies or biotin supplementation (which affects streptavidin-based immunoassays) can produce falsely elevated or falsely low results [6]. Patients should stop biotin supplements for at least 48-72 hours before blood draws, per FDA safety communication guidance.

The 2019 Endocrine Society position statement on biotin interference recommended that all endocrine laboratories include biotin warnings on requisition forms [17]. If you are taking high-dose biotin (5,000-10,000 mcg/day, common in hair and nail supplements), inform your clinician before any hormone blood test.